The strengths of this study lie in the fact that it is the first of its kind in Nigerian cervical cancer patients and it has contributed to the knowledge of EGFR and HER2 expression as well as their relationship to survival in cervical cancer patients. Here, ERBB2 is linked to cervical cancer.